UAB Biotechnologinės farmacijos centras "Biotechpharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2021 |
|---|
| 76,153,418 |
| 448,991 |
| 34,384,439 |
| 34,384,439 |
| 202,726 |
| 52.30 |
| 45.15 |
| 54,189,605 |
| 67,622,662 |
| 56,206,419 |
| 77,526,267 |
| 2022 |
|---|
| 123,919,188 |
| 709,651 |
| 60,120,244 |
| 60,120,244 |
| 344,292 |
| 56.37 |
| 48.52 |
| 97,117,629 |
| 58,745,860 |
| 85,544,582 |
| 82,060,375 |
| 2023 |
|---|
| 93,045,600 |
| 575,670 |
| 50,779,570 |
| 50,779,570 |
| 314,172 |
| 63.31 |
| 54.57 |
| 94,214,496 |
| 61,164,150 |
| 56,086,298 |
| 110,169,310 |
Register and
explore Okredo data| 2023 |
|---|
| 93,045,600 |
| 575,670 |
| 50,779,570 |
| 50,779,570 |
| 314,172 |
| 63.31 |
| 54.57 |
| 94,214,496 |
| 61,164,150 |
| 56,086,298 |
| 110,169,310 |
Register and
explore Okredo data2023
Turnover (€)
93,045,600 €
-25 % *
Sales per employee (€)
575,670 €-19 % *
Profit before tax (€)
50,779,570 €-16 % *
Net Profit (€)
50,779,570 €-16 % *
Profit per employee (€)
314,172 €-9 % *
Total profitability (%)
63.31 %
12.31 % *
Net profitability (%)
54.57 %12.47 % *
Equity (€)
94,214,496 €-3 % *
Amounts Payable And Liabilities (€)
61,164,150 €
4 % *
Non-current Assets (€)
56,086,298 €
-34 % *
CurrentAssets (€)
110,169,310 €34 % *